Literature DB >> 10988096

Familial sarcoidosis is linked to the major histocompatibility complex region.

M Schürmann1, P A Lympany, P Reichel, B Müller-Myhsok, K Wurm, M Schlaak, J Müller-Quernheim, R M du Bois, E Schwinger.   

Abstract

Sarcoidosis is a systemic granulomatous disorder associated with high CD4+ cell activity, but no pathogen is detectable. Clustering in families occurs, and the existence of a genetic predisposition to sarcoidosis is widely accepted. The major histocompatibility complex (MHC) is believed to contribute to this susceptibility. Many studies testing this hypothesis have produced conflicting results. We have genotyped 122 affected siblings from 55 families for seven DNA polymorphisms that flank and cover the MHC region on chromosome 6, and for HLA-DPB1, a candidate gene for granulomatous disorders. Multipoint nonparametric linkage (NPL) analysis showed linkage (NPL score > 2.5; p < 0.006) for the entire MHC region with a maximum NPL score of 3.2 (p = 0.0008) at marker locus D6S1666 in the Class III gene cluster. There was a significant excess of marker haplotype sharing among affected siblings. However, the frequency of HLA-DPB1 alleles on 104 shared chromosomes did not differ from that of a control group of founders from the family panel. Transmission disequilibrium was found for allele DPB1*0201, but only nine families contributed to this result. We conclude that genes of the MHC are involved in the genetic predisposition to sarcoidosis, but HLA-DPB1 alone does not sufficiently explain this fact.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988096     DOI: 10.1164/ajrccm.162.3.9901099

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

Review 1.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

2.  Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis.

Authors:  Igor Medica; Andrej Kastrin; Ales Maver; Borut Peterlin
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

3.  The bioinorganic chemistry and associated immunology of chronic beryllium disease.

Authors:  Brian L Scott; T Mark McCleskey; Anu Chaudhary; Elizabeth Hong-Geller; S Gnanakaran
Journal:  Chem Commun (Camb)       Date:  2008-05-09       Impact factor: 6.222

4.  Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.

Authors:  Johan Grunewald; Boel Brynedal; Pernilla Darlington; Magnus Nisell; Kerstin Cederlund; Jan Hillert; Anders Eklund
Journal:  Respir Res       Date:  2010-02-26

Review 5.  Selected Giant Cell Rich Lesions of the Temporal Bone.

Authors:  Anthony P Martinez; Jorge Torres-Mora
Journal:  Head Neck Pathol       Date:  2018-08-01

Review 6.  Cardiac sarcoidosis.

Authors:  Matthew M Zipse; William H Sauer
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

7.  Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Authors:  Hiroe Sato; Felix A Woodhead; Tariq Ahmad; Jan C Grutters; Paolo Spagnolo; Jules M M van den Bosch; Lisa A Maier; Lee S Newman; Sonoko Nagai; Takateru Izumi; Athol U Wells; Roland M du Bois; Kenneth I Welsh
Journal:  Hum Mol Genet       Date:  2010-08-03       Impact factor: 6.150

8.  [Familial uveitis. Forms and incidence in patients at the University Eye Hospital Tubingen].

Authors:  C M E Deuter; N Stübiger; K Siepmann; M Derse; M Zierhut
Journal:  Ophthalmologe       Date:  2003-09       Impact factor: 1.059

9.  Associations between TNF-α -308 A/G and lymphotoxin-α +252 A/G polymorphisms and susceptibility to sarcoidosis: a meta-analysis.

Authors:  Gwan Gyu Song; Jae-Hoon Kim; Young Ho Lee
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

10.  Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.

Authors:  Kathryn E McDougal; M Daniele Fallin; David R Moller; Zhimin Song; David J Cutler; Lori L Steiner; Garry R Cutting
Journal:  J Invest Dermatol       Date:  2009-02-19       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.